Please login to the form below

Not currently logged in
Email:
Password:
I have forgotten my password

Foundation Medicines

This page shows the latest Foundation Medicines news and features for those working in and with pharma, biotech and healthcare.

US start-up EQRx promises approach that will slash drug prices

US start-up EQRx promises approach that will slash drug prices

in 2018 – and  Blueprint Medicines which has just claimed its first approval for a high-priced cancer drug. ... Other key figures in EQRx include former Foundation Medicine and McKesson executive Melanie Nallicheri, who serves as president and chief

Latest news

  • AstraZeneca to develop Lynparza companion diagnostic AstraZeneca to develop Lynparza companion diagnostic

    To do so AZ has joined forces with molecular information firm Foundation Medicines, whose FoundationOne genomic profiling platform will be used to develop the test. ... Nina Mojas, global medicine lead for Lynparza at AstraZeneca, said: “Utilising

  • The distance travelled

    When medicines were approved, the community thought that prices were too high and wanted a greater say in the development and delivery of medicines. ... Unimaginable thirty years ago, most companies now collaborate with not-for-profit organisations like

More from news
Approximately 1 fully matching, plus 2 partially matching documents found.

Latest Intelligence

  • Interview: Harvey Berger and Timothy Clackson, Ariad Interview: Harvey Berger and Timothy Clackson, Ariad

    treatments.”. It's the results of strategy to “discover, develop and deliver our medicines without the additional input of pharma partners”, says Berger. ... We are building a strong commercial presence, but it is one that is built on what

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Apex.co.uk Events and Exhibition Stands

Apex.co.uk is one of the UK’s leading exhibition stand and event agencies, specialising in healthcare. We understand your communication goals,...

Latest intelligence

Diversity in clinical trials: looking back at our 2021 blogs
In this blog, we look back at the Innovative Trials' Equality & Diversity (E&D) committee blogs across 2021...
What does the future hold for Light-chain Amyloidosis?
Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape...
Webinar:
Securing a future for telehealth with immersive market research insights...

Quick links